Lupin has received final approval from the Food and Drug Administration (FDA) for Kaitlib Fe Chewable Tablets (norethindrone/ethinyl estradiol and ferrous fumarate), the generic version of Warner Chilcott’s Generess Fe Chewable Tablets.
Generess Fe is a progestin and estrogen combination contraceptive indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.
Kaitlib Fe will be available as 0.8mg/0.025mg norethindrone acetate/ethinyl estradiol with 75mg ferrous fumarate chewable tablets. It will be supplied in 3 x 28 blister packs.
For more information call (800) 399-2561 or visit Lupinpharmaceuticals.com.